Efficacy of Methionine Restriction and the PARP-inhibitor Olaparib and Their Combination on BRCA1 Mutant and Wild-type Triple-negative Breast Cancer Cell Lines
Anticancer Research · 2025
DOI: 10.21873/anticanres.17522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Mayuko Miki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Kobe University Graduate School of Medicine, Hyogo, Japan. Hauptthemen laut MEDLINE: Piperazines, Phthalazines, Triple Negative Breast Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Breast Surgery, Kobe University Graduate School of Medicine, Hyogo, Japan.
- Division of Breast Surgery, Kobe University Graduate School of Medicine, Hyogo, Japan; sachiko_inubushi@people.kobe-u.ac.jp.
- AntiCancer Inc, San Diego, CA, U.S.A.
- Department of Cardiovascular, Respiratory and Breast Surgery, Wakayama Medical University, Wakayama, Japan.
- AntiCancer Inc, San Diego, CA, U.S.A.; all@anticancer.com.
- Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.
Zitieren
APA
Miki, M., Inubushi, S., Han, Q., Inoue, S., Kunihisa, T., Tanino, H., & Hoffman, R. M. (2025). Efficacy of Methionine Restriction and the PARP-inhibitor Olaparib and Their Combination on BRCA1 Mutant and Wild-type Triple-negative Breast Cancer Cell Lines. Anticancer Research. https://doi.org/10.21873/anticanres.17522
Vancouver
Miki M, Inubushi S, Han Q, Inoue S, Kunihisa T, Tanino H, et al. Efficacy of Methionine Restriction and the PARP-inhibitor Olaparib and Their Combination on BRCA1 Mutant and Wild-type Triple-negative Breast Cancer Cell Lines. Anticancer Research. 2025. doi:10.21873/anticanres.17522
BibTeX
@article{Miki2025,
author = {Miki, Mayuko and Inubushi, Sachiko and Han, Qinghong and Inoue, Shotaro and Kunihisa, Tomonari and Tanino, Hirokazu and Hoffman, Robert M},
title = {Efficacy of Methionine Restriction and the PARP-inhibitor Olaparib and Their Combination on BRCA1 Mutant and Wild-type Triple-negative Breast Cancer Cell Lines},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17522}
}
EUVIMED